At a glance
ClinicalIndex Comparison RecordN/ACompleted· 113 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Longitudinal Assessment of Cardiovascular and Renal Health in Patients With Hepatitis-C (CARE-Hep C)
In Brief
An observational study for Hepatitis C. Completed, enrolled 113 participants across 13 sites in 2 countries.
Detailed Summary
The purpose of this study is to monitor the cardiovascular and renal health of patients who previously took BMS-986094 (an investigational medication for hepatitis C) in comparison to hepatitis C infected patients who have never taken BMS-986094.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHepatitis C
CountriesPuerto Rico, United States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 2013
Enrollment StartMay 2013
Primary CompletionMar 2018
TodayJul 2026
First PostedMay 3, 2013
Enrollment StartMay 10, 2013
Primary CompletionMar 19, 2018
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 13.2 years ago